Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: How, when and why?

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 374-379

  Graham, Trevor A ^a   McDonald, Stuart A C ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Clonality; Genetic diversity; Genetic evolution

Indexed keywords

PROTEIN P16;

BARRETT ESOPHAGUS; CANCER GROWTH; CARCINOGENESIS; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GENE INACTIVATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; INFLAMMATION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; ADENOCARCINOMA; BIOLOGICAL MODEL; CELL TRANSFORMATION; DISEASE COURSE; ESOPHAGUS TUMOR; GENETICS; PATHOLOGY; PHYSIOLOGY; TIME;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENETIC HETEROGENEITY; GENETIC VARIATION; HUMANS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 77953249049     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380374     Document Type: Review

References (45)

1. Maley, C.C. (2007) Multistage carcinogenesis in Barrett's esophagus. Cancer Lett. 245, 22-32
2. Wild, C.P. and Hardie, L.J. (2003) Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat. Rev. Cancer 3, 676-684
3. Reid, B.J., Weinstein, W.M., Lewin, K.J., Haggitt, R.C., VanDeventer, G., DenBesten, L. and Rubin, C.E. (1988) Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94, 81-90
4. Barrett, M.T., Sanchez, C.A., Prevo, L.J., Wong, D.J., Galipeau, P.C., Paulson, T.G., Rabinovitch, P.S. and Reid, B.J. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet. 22, 106-109
5. Maley, C.C., Galipeau, P.C., Li, X., Sanchez, C.A., Paulson, T.G., Blount, P.L. and Reid, B.J. (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64, 7629-7633
6. Maley, C.C., Galipeau, P.C., Li, X., Sanchez, C.A., Paulson, T.G. and Reid, B.J. (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res. 64, 3414-3427
7. Michael, D., Beer, D.G., Wilke, C.W., Miller, D.E. and Glover, T.W. (1997) Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene 15, 1653-1659
8. Onwuegbusi, B.A., Aitchison, A., Chin, S.-F., Kranjac, T., Mills, I., Huang, Y., Lao-Sirieix, P., Caldas, C. and Fitzgerald, R.C. (2006) Impaired transforming growth factor β signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation. Gut 55, 764-774
9. Onwuegbusi, B.A., Rees, J.R.E., Lao-Sirieix, P. and Fitzgerald, R.C. (2007) Selective loss of TGFβ Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell lines. PLoS ONE 2, e177
10. Barrett, M.T., Sanchez, C.A., Galipeau, P.C., Neshat, K., Emond, M. and Reid, B.J. (1996) Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13, 1867-1873
11. Dolan, K., Garde, J., Walker, S.J., Sutton, R., Gosney, J. and Field, J.K. (1999) LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum. Pathol. 30, 1508-1514
12. Blount, P.L., Meltzer, S.J., Yin, J., Huang, Y., Krasna, M.J. and Reid, B.J. (1993) Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 90, 3221-3225
13. Clément, G., Braunschweig, R., Pasquier, N., Bosman, F.T. and Benhattar, J. (2006) Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J. Pathol. 208, 100-107
14. Clément, G., Braunschweig, R., Pasquier, N., Bosman, F.T. and Benhattar, J. (2006) Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 25, 3084-3092
15. Schulmann, K., Sterian, A., Berki, A., Yin, J., Sato, F., Xu, Y., Olaru, A., Wang, S., Mori, Y., Deacu, E. et al. (2005) Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24, 4138-4148
16. Sato, F., Shibata, D., Harpaz, N., Xu, Y., Yin, J., Mori, Y., Wang, S., Olaru, A., Deacu, E., Selaru, F.M. et al. (2002) Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res. 62, 6820-6822
17. Young, J., Biden, K.G., Simms, L.A., Huggard, P., Karamatic, R., Eyre, H.J., Sutherland, G.R., Herath, N., Barker, M., Anderson, G.J. et al. (2001) HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc. Natl. Acad. Sci. U.S.A. 98, 265-270
18. Ito, K., Liu, Q., Salto-Tellez, M., Yano, T., Tada, K., Ida, H., Huang, C., Shah, N., Inoue, M., Rajnakova, A. et al. (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 65, 7743-7750
19. Li, Q.L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.i., Chi, X.Z., Lee, K.Y., Nomura, S., Lee, C.W., Han, S.B. et al. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124
20. Tselepis, C., Morris, C.D., Wakelin, D., Hardy, R., Perry, I., Luong, Q.T., Harper, E., Harrison, R., Attwood, S.E.A. and Jankowski, J.A.Z. (2003) Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52, 174-180
21. Sarbia, M., Arjumand, J., Wolter, M., Reifenberger, G., Heep, H. and Gabbert, H.E. (2001) Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus. Am. J. Clin. Pathol. 115, 835-840
22. Arber, N., Shapira, I., Ratan, J., Stern, B., Hibshoosh, H., Moshkowitz, M., Gammon, M., Fabian, I. and Halpern, Z. (2000) Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 118, 1045-1050
23. Sommerer, F., Vieth, M., Markwarth, A., Röhrich, K., Vomschloss, S., May, A., Ell, C., Stolte, M., Hengge, U.R., Wittekind, C. et al. (2004) Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene 23, 554-558
24. Gil, J. and Peters, G. (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677
25. INK4a lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res. 61, 8284-8289
26. Miller, C.T., Lin, L., Casper, A.M., Lim, J., Thomas, D.G., Orringer, M.B., Chang, A.C., Chambers, A.F., Giordano, T.J., Glover, T.W. et al. (2006) Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25, 409-418
27. Lin, L., Wang, Z., Prescott, M.S., Van Dekken, H., Thomas, D.G., Giordano, T.J., Chang, A.C., Orringer, M.B., Gruber, S.B., Moran, J.V. et al. (2006) Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer 45, 319-331
28. Doak, S.H., Jenkins, G.J.S., Parry, E.M., D'Souza, F.R., Griffiths, A.P., Toffazal, N., Shah, V., Baxter, J.N. and Parry, J.M. (2003) Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut 52, 623-628
29. McCombs, R. (1930) A hypothesis on the causation of cancer. Science 72, 423-424
30. Nowell, P.C. (1976) The clonal evolution of tumor cell populations. Science 194, 23-28
31. Jones, S., Chen, W.-D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M.A., Siegel, C., Velculescu, V.E. et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. U.S.A. 105, 4283-4288
32. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170
33. Chatelain, D. and Fléjou, J.-F. (2003) High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Virchows Arch. 442, 18-24
34. Galipeau, P.C., Prevo, L.J., Sanchez, C.A., Longton, G.M. and Reid, B.J. (1999) Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J. Natl. Cancer Inst. 91, 2087-2095
35. Eads, C.A., Lord, R.V., Kurumboor, S.K., Wickramasinghe, K., Skinner, M.L., Long, T.I., Peters, J.H., DeMeester, T.R., Danenberg, K.D., Danenberg, P.V. et al. (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 60, 5021-5026
36. Maley, C.C., Galipeau, P.C., Finley, J.C., Wongsurawat, V.J., Li, X., Sanchez, C.A., Paulson, T.G., Blount, P.L., Risques, R.-A., Rabinovitch, P.S. et al. (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468-473
37. Leedham, S.J., Preston, S.L., McDonald, S.A.C., Elia, G., Bhandari, P., Poller, D., Harrison, R., Novelli, M.R., Jankowski, J.A. and Wright, N.A. (2008) Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 57, 1041-1048
38. Tomlinson, I.P.M., Lambros, M.B.K. and Roylance, R.R. (2002) Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34, 349-353
39. Leedham, S.J. and Wright, N.A. (2008) Human tumour clonality assessment: flawed but necessary. J. Pathol. 215, 351-354
40. Eisen, G.M., Sandler, R.S., Murray, S. and Gottfried, M. (1997) The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am. J. Gastroenterol. 92, 27-31
41. Dvorak, K., Payne, C., Chavarria, M., Ramsey, L., Dvorakova, B., Bernstein, H., Holubec, H., Sampliner, R., Guy, N., Condon, A. et al. (2007) Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56, 763-771
42. Olliver, J.R., Hardie, L.J., Dexter, S., Chalmers, D. and Wild, C.P. (2003) DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8, 509-521
43. Moreno, E. (2008) Is cell competition relevant to cancer? Nat. Rev. Cancer 8, 141-147
44. Tomlinson, I.P. (1997) Game-theory models of interactions between tumour cells. Eur. J. Cancer. 33, 1495-1500
45. Kinzler, K.W. and Vogelstein, B. (1998) Landscaping the cancer terrain. Science 280, 1036-1037